Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Trends in Cancer|January 25, 2025
Revumenib: a new era in acute leukemia treatmentDavid A Martínez-Gamboa, Justin KanerImmunotherapy|November 17, 2015
Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1Amer Assal, Justin Kaner, Gopichand Pendurti, et al.Trends in Cancer|July 10, 2024
Current landscape of CD3 bispecific antibodies in hematologic malignanciesJoshua Kassner, Basma Abdellatif, Samuel Yamshon, et al.Cold Spring Harbor Perspectives in Medicine|October 17, 2019
Clonal Hematopoiesis and Premalignant DiseasesJustin Kaner, Pinkal Desai, Nuria Mencia-Trinchant, et al.Methods in Enzymology|June 2, 2020
Chemical probes and methods for single-cell detection and quantification of epichaperomes in hematologic malignanciesSwathi Merugu, Sahil Sharma, Justin Kaner, et al.Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|July 25, 2023
Detection of Hybrid Fusion Transcripts, Aberrant Transcript Expression, and Specific Single Nucleotide Variants in Acute Leukemia and Myeloid Disorders with Recurrent Gene RearrangementsYuewei Li, Kaifang Deng, Justin Kaner, et al.Antimicrobial Agents and Chemotherapy|June 26, 2026
Colonization with extended-spectrum and AmpC β-lactamase-producing Enterobacterales and bacteremia risk in patients with acute leukemia who receive induction chemotherapy without fluoroquinolone prophylaxisKate Stoeckle, Ivo Sah Bandar, Liang Chen, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
Single-cell spatial mapping reveals dynamic bone marrow microarchitectural alterations and enhances clinical diagnostics in MDSRyan Nachman, Aleksandra Kopacz, Caitlin Unkenholz, et al.Leukemia|July 1, 2026
Spatial remodeling of bone marrow architecture defines tissue-state signatures of disease activity and therapeutic response in myelodysplastic neoplasmsRyan Nachman, Aleksandra Kopacz, Caitlin Unkenholz, et al.The Journal of Biological Chemistry|December 3, 2016
Notch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal CancerTushar D Bhagat, Yiyu Zou, Shizheng Huang, et al.Pageof 2